Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis

For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now permit randomized, controlled trials of shortened-duration, all-oral treatments for rifampin-resistant t...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The New England journal of medicine Ročník 392; číslo 5; s. 468 - 482
Hlavní autori: Guglielmetti, Lorenzo, Khan, Uzma, Velásquez, Gustavo E., Gouillou, Maelenn, Abubakirov, Amanzhan, Baudin, Elisabeth, Berikova, Elmira, Berry, Catherine, Bonnet, Maryline, Cellamare, Matteo, Chavan, Vijay, Cox, Vivian, Dakenova, Zhanna, de Jong, Bouke Catherine, Ferlazzo, Gabriella, Karabayev, Aydarkhan, Kirakosyan, Ohanna, Kiria, Nana, Kunda, Mikanda, Lachenal, Nathalie, Lecca, Leonid, McIlleron, Helen, Motta, Ilaria, Toscano, Sergio Mucching, Mushtaque, Hebah, Nahid, Payam, Oyewusi, Lawrence, Panda, Samiran, Patil, Sandip, Phillips, Patrick P. J., Ruiz, Jimena, Salahuddin, Naseem, Garavito, Epifanio Sanchez, Seung, Kwonjune J., Ticona, Eduardo, Trippa, Lorenzo, Vasquez, Dante E. Vargas, Wasserman, Sean, Rich, Michael L., Varaine, Francis, Mitnick, Carole D.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Massachusetts Medical Society 30.01.2025
Predmet:
ISSN:0028-4793, 1533-4406, 1533-4406
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Buďte prvý, kto okomentuje tento záznam!
Najprv sa musíte prihlásiť.